Cross Country Healthcare, Inc. (CCRN)
NASDAQ: CCRN · Real-Time Price · USD
9.32
+0.15 (1.64%)
Jan 30, 2026, 4:00 PM EST - Market closed
Cross Country Healthcare Analyst Ratings
Total Analysts
3
Consensus Rating
Hold
Price Target
$13.81
Upside
+48.18%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold Maintains $17 → $9 | Hold | Maintains | $17 → $9 | -3.43% | Dec 9, 2025 |
| Barrington Research | Barrington Research | Hold Maintains $19 | Hold | Maintains | $19 | +99.68% | Jun 17, 2025 |
| UBS | UBS | Hold Maintains $19 → $17 | Hold | Maintains | $19 → $17 | +77.04% | May 13, 2025 |
| Barrington Research | Barrington Research | Hold Maintains $19 | Hold | Maintains | $19 | +99.68% | Mar 14, 2025 |
| UBS | UBS | Hold Maintains $14 → $19 | Hold | Maintains | $14 → $19 | +99.68% | Mar 6, 2025 |
| JMP Securities | JMP Securities | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Feb 6, 2025 |
| Barrington Research | Barrington Research | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Dec 10, 2024 |
| Truist Securities | Truist Securities | Hold Maintains $15 → $19 | Hold | Maintains | $15 → $19 | +99.68% | Dec 5, 2024 |
| UBS | UBS | Hold Maintains $19 → $14 | Hold | Maintains | $19 → $14 | +50.21% | Nov 8, 2024 |
| Benchmark | Benchmark | Strong Buy Maintains $19 → $18 | Strong Buy | Maintains | $19 → $18 | +93.13% | Nov 7, 2024 |
| Truist Securities | Truist Securities | Hold Maintains $17 → $15 | Hold | Maintains | $17 → $15 | +60.94% | Oct 21, 2024 |
| Barrington Research | Barrington Research | Buy Maintains $21 → $19 | Buy | Maintains | $21 → $19 | +103.86% | Aug 8, 2024 |
| Truist Securities | Truist Securities | Hold Maintains $16 → $17 | Hold | Maintains | $16 → $17 | +82.40% | Aug 1, 2024 |
| Barrington Research | Barrington Research | Buy Maintains $24 → $21 | Buy | Maintains | $24 → $21 | +125.32% | May 6, 2024 |
| Benchmark | Benchmark | Strong Buy Maintains $21 → $19 | Strong Buy | Maintains | $21 → $19 | +103.86% | May 2, 2024 |
| Barrington Research | Barrington Research | Buy Maintains $26 → $24 | Buy | Maintains | $26 → $24 | +157.51% | Feb 27, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.